ACTRN12612000661875招募中未知
Cardiac function in women with preeclampsia after treatment interventions
The Royal Women's Hosptial0 个研究点目标入组 320 人开始时间: 2012年6月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- Female
入选标准
- •Women with preeclampsia - non-labouring women, non-smokers, no vasoactive treatments or intravenous fluids adninstered, no previous cardiac disease or uterine abnormality.
- •Healthy pregnant women - non-labouring women, no significant medical or surgical illness, non smokers, no uterine abnormalities and normally defined placentation. They will not be receiving any vasoactive medication including salbutamol or thyroid replacement hormones.
排除标准
- •labouring women, current administration of vasoactive drugs including salbutamol and thyroxine, pre-existing or gestational diabetes, smoking, and a known uterine abnormality.
研究者
相似试验
招募中
不适用
Cardiac adaptation and recovery after preeclampsiapreeclampsia100192801001027310038430NL-OMON53038Medisch Universitair Ziekenhuis Maastricht1,358
已完成
1 期
Treating early onset severe preeclampsia with pravastatin: an early phase clinical trialPreeclampsiaReproductive Health and Childbirth - Fetal medicine and complications of pregnancyReproductive Health and Childbirth - Antenatal careACTRN12613000268741The Mercy Hospital for Women12
尚未招募
不适用
Cardiovascular disease and preeclampsia.Preeclampsia, cardiovascular disease, renal function, hemodynamicsPre-eclampsie, hart- en vaatziekten, renale functie, hemodynamiekNL-OMON21206Profileringsfonds, azM30
已完成
不适用
Cardiovascular disease in formerly preeclamptic womehypertensive disorders of pregnancyToxemia1002690610057166NL-OMON33561Academisch Ziekenhuis Maastricht30
已完成
2 期
Postpartum Severe Preeclampsia Maternal Outcomes In 12-Hours Versus 24-Hours Maintenance Doses of Magnesium Sulfate Administration: Randomized Control TrialTCTR20230811008ocal, in Arifin Achmad Hospital80